These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Psychopharmacology of the anxiety disorders. Ballenger JC. Psychiatr Clin North Am; 1984 Dec; 7(4):757-71. PubMed ID: 6151647 [Abstract] [Full Text] [Related]
3. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia. Sheehan DV. Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580 [Abstract] [Full Text] [Related]
5. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks. Buigues J, Vallejo J. J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985 [Abstract] [Full Text] [Related]
6. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature]. Erfurth A, Schmauss M. Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650 [Abstract] [Full Text] [Related]
7. Pharmacotherapy of anxious disorders. Bourin M, Lambert O. Hum Psychopharmacol; 2002 Dec; 17(8):383-400. PubMed ID: 12457374 [Abstract] [Full Text] [Related]
8. An open trial of MAO inhibitors in bulimia. Stewart JW, Walsh BT, Wright L, Roose SP, Glassman AH. J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746 [Abstract] [Full Text] [Related]
9. Clonazepam in the treatment of obsessive compulsive disorder associated with panic disorder in one patient. Bodkin JA, White K. J Clin Psychiatry; 1989 Jul; 50(7):265-6. PubMed ID: 2738031 [Abstract] [Full Text] [Related]
10. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine]. Servant D, Bailly D, Le Seac'h H, Parquet PJ. Encephale; 1990 Jul; 16 Spec No():359-62. PubMed ID: 2120029 [Abstract] [Full Text] [Related]
11. Alprazolam in the treatment of social phobia. Lydiard RB, Laraia MT, Howell EF, Ballenger JC. J Clin Psychiatry; 1988 Jan; 49(1):17-9. PubMed ID: 3335485 [Abstract] [Full Text] [Related]
12. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)]. Bouvard M, Robbe-Grillet P, Milliery M, Pham S, Amireche S, Fanget F, Guerin J, Cottraux J. Encephale; 2001 Jan; 27(3):229-37. PubMed ID: 11488253 [Abstract] [Full Text] [Related]
13. Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification. Sheehan DV. J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):29-36. PubMed ID: 6429129 [Abstract] [Full Text] [Related]
15. Child panic revisited. Klein DF, Mannuzza S, Chapman T, Fyer AJ. J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):112-4; discussion 114-6. PubMed ID: 1537761 [Abstract] [Full Text] [Related]
16. [Antidepressive agents and anxiety]. Lépine JP, Chignon JM. Rev Prat; 1991 Mar 21; 41(9):814-20. PubMed ID: 2047718 [No Abstract] [Full Text] [Related]
17. The phenomenon of panic. Barlow DH, Vermilyea J, Blanchard EB, Vermilyea BB, Di Nardo PA, Cerny JA. J Abnorm Psychol; 1985 Aug 21; 94(3):320-8. PubMed ID: 4031229 [No Abstract] [Full Text] [Related]
18. Anxiety: differential diagnosis and treatment from a biologic perspective. Davis JM, Nasr S, Spira N, Vogel C. J Clin Psychiatry; 1981 Nov 21; 42(11 Pt 2):4-14. PubMed ID: 7037755 [No Abstract] [Full Text] [Related]
19. A clinical trial of clomipramine and diazepam in the treatment of phobic and obsessional illness. Waxman D. J Int Med Res; 1977 Nov 21; 5 Suppl 5():99-110. PubMed ID: 598611 [Abstract] [Full Text] [Related]
20. Let's talk facts about anxiety disorders. American Psychiatric Association. J Okla State Med Assoc; 2008 Dec 21; 101(12):347-50. PubMed ID: 19177997 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]